Theravance Biopharma, Inc. Interest Payable, Current
Theravance Biopharma, Inc. (TBPH) had Interest Payable, Current of $3.99 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2023-03-01
- 2022-06-30: Interest Payable, Current $3.99M.
- 2022-03-31: Interest Payable, Current $5.84M.
- 2021-12-31: Interest Payable, Current $1.25M; Interest Payable, Current as first filed $3.94M.
- 2021-09-30: Interest Payable, Current $5.81M.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2022-06-30 | $3.99M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $5.84M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $1.25M 10-K · filed 2023-03-01 | $3.94M 10-K · filed 2022-02-28 |
| 2021-09-30 | $5.81M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $3.90M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $5.80M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $3.97M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $5.79M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.70M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.32M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $5.66M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $7.57M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $5.76M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $10.24M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $3.09M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |